In addition, SHP099 inhibits the proliferation of RTK-driven human cancer cells by inhibiting Ras/Erk signaling, so drug inhibition of SHP2 is one of the effective strategies for cancer treatment (Chen et al., 2016). This evidence concerns the gene PTPN11 and cancer.